Zhejiang Sansheng Mandi Pharmaceutical

Zhejiang Sansheng Mandi Pharmaceutical is a specialized pharmaceutical company based in Hangzhou, China, and a key subsidiary of 3SBio. The company is dedicated to the dermatology sector, with a primary focus on hair health and the treatment of alopecia. Its flagship product, Mandi, was the first minoxidil tincture approved in China and currently maintains a leading position in the domestic hair regrowth market. Beyond its core minoxidil products, the company is expanding its portfolio to include innovative formulations such as foams and combination therapies. Zhejiang Sansheng Mandi Pharmaceutical integrates research, large-scale manufacturing, and an extensive retail distribution network to serve millions of patients. The company continues to invest in clinical research to broaden the indications and efficacy of its dermatological offerings.